HSBC WAR. CALL 12/28 BAYN/ DE000HS57ES6 /
| 2024-06-24 5:37:32 PM | Chg.+0.0100 | Bid7:34:12 PM | Ask7:34:12 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.4900EUR | +2.08% | 0.4800 Bid Size: 20,000 |
0.5200 Ask Size: 20,000 |
BAYER AG NA O.N. | 35.00 EUR | 2028-12-13 | Call |
GlobeNewswire
2:00 PM
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at The...
GlobeNewswire
2:00 PM
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results ...
GlobeNewswire
05-30
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
05-30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
05-28
Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
GlobeNewswire
05-02
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire
04-18
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
04-16
AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire
04-11
Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire
03-25
BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire
03-06
BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
GlobeNewswire
03-04
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
GlobeNewswire
02-15
2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire
02-13
Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
